FdaApplication
NDA 206829
Identifiers
- fda_app_no: NDA206829
Properties
| Property | Value |
|---|---|
| applicant_name | CUBIST PHARMACEUTICALS LLC |
| application_type | NDA |
| approval_date | 2014-12-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | EQ 1GM BASE/VIAL;EQ 0.5GM BASE/VIAL | POWDER;INTRAVENOUS |
1 product